Anaplastic Large-Cell Lymphoma T Anaplastic Lymphoma Kinase-Positive Associated With Crohn’s Disease Undergoing Treatment With Azathioprine: A Case Report

Pamela Cristina Gaspar, Manoela Lira Reis, Kaite Cristiane Peres, Renata Cristina Messores Rudolf-Oliveira, Vanessa Mengatto, Joanita Angela Gonzaga Del-Moral, Maria Claudia Santos-Silva

Abstract


Anaplastic large-cell lymphoma (ALCL) is a subgroup of non-Hodgkin lymphoma (NHL) that the etiology is not totally elucidated. Hereditary, environmental, occupational and dietary factors are believed to be related with the development of NHL. The use of some immunomodulatory drugs such as azathioprine at the treatment of Crohn’s disease (CD) has been described in the literature causing NHL. We reported a clinical case of a possible association between NHL and Crohn’s treatment. Furthermore, ALCL is a rare subtype of NHL, thus, it has a difficult diagnostic. So in this study we also demonstrated clinical characteristics and laboratory findings that are helpful to rapid and accurate diagnostic of ALCL.




J Hematol. 2014;3(3):91-94
doi: http://dx.doi.org/10.14740/jh118w


Keywords


Anaplastic large-cell lymphoma; Crohn’s disease; Non-Hodgkin lymphoma

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!